Beni Boursi

専門分野: Clinical oncologist
21年の経験
話します:
English, Hebrew
オンラインコンサルテーション：利用可能
勤務先: イスラエル, ラマト・ガン, シェバ医療センター
Internationally recognized leader in microbial modulation for cancer therapy and founder of the ECOG-ACRIN Microbiome Working Group.
Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Beni Boursiとのオンラインコンサルテーション

便利で簡単

100%安全で機密

$650

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Department:

Gastrointestinal Cancer Department

Specialties:

Internal Medicine, Medical Oncology, Cancer Epidemiology

Prof. Ben Boursi is a leading specialist in Internal Medicine, Medical Oncology, and Radiotherapy at Sheba Medical Center. He earned his medical degree with distinction (cum laude) from the School of Medicine at Tel Aviv University.

He completed his residency in Internal Medicine at Sourasky Medical Center in Tel Aviv, followed by advanced subspecialty training in Gastrointestinal Oncology and Cancer Epidemiology at the University of Pennsylvania, USA.

Academic and Research Appointments

Prof. Boursi holds an academic position within the Department of Epidemiology and Preventive Medicine at the School of Medicine, Tel Aviv University. In addition, he serves as an Associate Scholar at the Perelman School of Medicine, University of Pennsylvania.

Research and Scientific Contributions

Prof. Boursi’s research is centered on developing innovative therapeutic approaches in oncology, with a particular focus on the role of the microbiome in cancer development and treatment response.

He is internationally recognized as a leader in microbial modulation in cancer therapy and founded the ECOG-ACRIN Microbiome Working Group. His work has been published in leading scientific journals, including Science, and presented at major global oncology conferences, as well as featured in ASCO educational platforms and podcasts.

Alongside his research, Prof. Boursi is actively involved in academic teaching, delivering lectures on host–microbiome interactions at Tel Aviv University and Bar-Ilan University.

His research also extends to cancer prevention and early detection. He has developed predictive models for early diagnosis of colorectal and pancreatic cancers, which are currently undergoing clinical evaluation.

Clinical Expertise

Gastrointestinal oncology

Current Position

Physician, Gastrointestinal Cancer Department

Education and Training

B.Med.Sc (Summa cum laude), School of Medicine, Tel Aviv University

MD (Magna cum laude), School of Medicine, Tel Aviv University

Clinical and Research Fellowship in Gastrointestinal Oncology and Cancer Epidemiology, Perelman School of Medicine, University of Pennsylvania

Elective Training in Medical Oncology, MD Anderson Cancer Center

Elective Training in Medical Oncology, Mayo Clinic

Advanced Research Training, Weizmann Institute of Science

Board Certifications